Antineoplastic
Showing 1 - 25 of 1,426
Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)
Recruiting
- Drug-Induced Acute Liver Injury
- Bicyclol tablets
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 2, 2023
Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))
Recruiting
- Cancer
- Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Jul 18, 2022
Quality of Life, Oral Mucositis, Dental Plaque Trial in Barcelona (The probiotic to be used in the intervention corresponds to
Enrolling by invitation
- Quality of Life
- +5 more
- The probiotic to be used in the intervention corresponds to PRODEFEN Plus manufactured by ITALFARMACO S.A. laboratory
- Placebo
-
Barcelona, SpainUniversity of Barcelona
Nov 9, 2023
Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)
Recruiting
- Breast Cancer
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 13, 2023
Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw
Recruiting
- Advanced Ovarian Carcinoma
- +7 more
-
Bydgoszcz, Kujawsko-pomorskie, Poland
- +2 more
Mar 7, 2023
Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])
Not yet recruiting
- Neoplasms
- +2 more
- Nivolumab Injection [Opdivo]
- (no location specified)
Jul 19, 2023
Digestive System Tumors, Thoracic Tumors Trial in Lille (Emotional skills, Short free talk and relaxation)
Recruiting
- Digestive System Neoplasms
- Thoracic Neoplasms
- Emotional skills
- Short free talk and relaxation
-
Lille, FranceHôpital Calmette,CHU
Jul 4, 2022
COVID Trial in Vienna (Azithromycin 500 milligram (mg) oral Tablet, Placebo)
Completed
- COVID
- Azithromycin 500 milligram (mg) oral Tablet
- Placebo
-
Vienna, AustriaAKH Vienna, Department for Internal Medicine I, Oncology
Apr 6, 2022
Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)
Recruiting
- Advanced Pancreatic Cancer
- CT-707
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 17, 2022
NSCLC, Antineoplastic Agents Trial in Edmonton (Experimental intervention)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Antineoplastic Agents
- Experimental intervention
-
Edmonton, Alberta, CanadaCross Cancer Institute
May 23, 2022
Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in
Recruiting
- Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
-
Columbus, Ohio
- +9 more
Aug 1, 2022
Amyloidosis Trial in Boston (blood collection, bone marrow collection)
Completed
- Amyloidosis
- blood collection
- bone marrow collection
-
Boston, MassachusettsBoston Medical Center
Sep 8, 2021
Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Recruiting
- Cancer
- Atrial Fibrillation
- Low molecular weight heparin
-
Thessaloniki, Greece
- +1 more
Feb 14, 2022
Reporting of Antibody-Drug Conjugate Associated Sepsis-related
Completed
- Sepsis (SMQ)
- +2 more
- Antibody-Drug Conjugate
- Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
-
Changsha, Hunan, ChinaCentral South University
Jun 19, 2022
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Esophageal Squamous Cell Carcinoma Trial (Combination (S095033 + paclitaxel))
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Combination (S095033 + paclitaxel)
- (no location specified)
Mar 28, 2022
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)
Not yet recruiting
- Breast Cancer
- +2 more
-
Concord, New South Wales, Australia
- +4 more
May 30, 2023
Response to Antineoplastic Treatment of Metastatic Cancer
Recruiting
- Metastatic Cancer
- blood sample collection
-
Linz, Upper Austria, AustriaOrdensklinikum Linz
Mar 9, 2021
Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)
Recruiting
- Hormone Receptor Positive Breast Carcinoma
- +6 more
- Liquid biopsy and CT scan
-
Bergame, Bergamo, Italy
- +6 more
Apr 13, 2023
NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Shanghai, Shanghai, China
- +1 more
Mar 17, 2022
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Responsible Side Effects Management in Oncology
Completed
- Pharmacovigilance
- +2 more
-
Zagreb, Croatia, Europe, CroatiaUHC Sestre milorsdnice
Nov 4, 2020